Literature DB >> 3523268

Anterior pituitary dysfunction in patients with chronic renal failure treated by hemodialysis or continuous ambulatory peritoneal dialysis.

R S Rodger, J H Dewar, S J Turner, M J Watson, M K Ward.   

Abstract

Cortisol, prolactin, and growth hormone responses to insulin-induced hypoglycemia were measured in 20 patients undergoing continuous ambulatory peritoneal dialysis or intermittent hemodialysis. The plasma cortisol responses were normal; however, the increments in serum prolactin and growth hormone concentrations were impaired in most patients. The growth hormone responses were lower (p less than 0.05) in those patients treated by continuous ambulatory peritoneal dialysis, but there were no other significant differences between the two patient groups. These results show that anterior pituitary dysfunction persists in some patients with chronic renal failure despite maintenance dialysis therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3523268     DOI: 10.1159/000183824

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

Review 1.  Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.

Authors:  B Tönshoff; F Schaefer; O Mehls
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

2.  Role of Growth Hormone Deficiency and Treatment in Chronic Kidney Disease.

Authors:  Diptesh Gupta; Michael Gardner; Adam Whaley-Connell
Journal:  Cardiorenal Med       Date:  2011-07-26       Impact factor: 2.041

3.  Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.

Authors:  P Trelewicz; W Grzeszczak; R Drabczyk
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 4.  Systemic illness.

Authors:  Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Ettore C degli Uberti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.